Table 1 Baseline Characteristics Stratified by Median Level of MAPSE

Age (±SD)

57.9 (±14.7)

59.7 (±14.6)

56.2 (±14.6)

0.017

Male %

44.8

47.7

42.0

0.248

BMI (±SD)

30.6 (±6.4)

31.0 (±6.5)

31.1 (±6.3)

0.876

Diabetes %

32.5

38.5

26.8

0.013

Hyperlipidemia %

52.0

56.9

47.3

0.055

Smoking %

18.0

23.6

12.7

0.005

Hypertension %

73.8

76.4

71.2

0.238

Known CAD %

31.1

36.6

25.9

0.020

Prior MI %

13.3

16.4

10.2

0.069

Prior PCI %

15.8

19.5

12.2

0.045

Prior CABG %

3.8

3.1

4.4

0.490

NYHA class

0.6 (±0.9)

0.5 (±0.9)

0.6 (±1.0)

0.295

Heart Failure %

 None

69.2

70.7

67.8

0.543

 NYHA 1

12.1

12.6

11.6

0.760

 NYHA 2

12.3

11.5

13.1

0.642

 NYHA 3

5.4

4.7

6.0

0.564

 NYHA 4

0.5

0.5

0.5

0.977

Antiplatelet Drug %

53.3

52.5

54.1

0.788

Statin %

50.1

49.6

52.1

0.684

ACE inhibitor %

40.4

43.9

40.0

0.235

Beta Blocker %

64.2

64.7

63.7

0.853

Diuretic %

46.5

42.0

50.7

0.144

LVEF (±SD)

58.9 (±13.7)

55.5 (±15.6)

62.2 (±10.7)

<0.001

LV mass g (±SD)

118.8 (±43.3)

123.6 (±48.1)

114.6 (±38.3)

0.039

LGE present %

20.9

26.7

15.3

0.006